From Casetext: Smarter Legal Research

Astrazeneca LP v. Mylan Pharms. Inc.

UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
Sep 21, 2011
2011-1506 (Fed. Cir. Sep. 21, 2011)

Opinion

2011-1506

09-21-2011

ASTRAZENECA LP, AKTIEBOLAGET DRACO, KBI INC., AND KBI-E INC., Plaintiffs-Appellants, v. MYLAN PHARMACEUTICALS INC., Defendant-Appellee.


NOTE: This order is nonprecedential.

Appeal from the United States District Court for the District of Delaware in case no. 08-CV-0453, Chief Judge Gregory M. Sleet.

ON MOTION


ORDER

Astrazeneca LP, Aktiebolaget Draco, KBI Inc., and KBI-E Inc. move for a 14-day extension of time, until October 14, 2011, to file their principal brief. Mylan Pharmaceuticals, Inc. opposes.

Upon consideration thereof,

IT IS ORDERED THAT:

The motion is granted.

FOR THE COURT

Jan Horbaly

Clerk

George F. Pappas, Esq.

Nicole W. Stafford, Esq.

s21


Summaries of

Astrazeneca LP v. Mylan Pharms. Inc.

UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT
Sep 21, 2011
2011-1506 (Fed. Cir. Sep. 21, 2011)
Case details for

Astrazeneca LP v. Mylan Pharms. Inc.

Case Details

Full title:ASTRAZENECA LP, AKTIEBOLAGET DRACO, KBI INC., AND KBI-E INC.…

Court:UNITED STATES COURT OF APPEALS FOR THE FEDERAL CIRCUIT

Date published: Sep 21, 2011

Citations

2011-1506 (Fed. Cir. Sep. 21, 2011)